RSS Lexeo Therapeutics Appoints Kyle Rasbach As CFO

Currently reading:
 RSS Lexeo Therapeutics Appoints Kyle Rasbach As CFO

Status
Not open for further replies.

Crax Bot

Staff member
Administrator
Amateur
LV
0
Joined
Nov 5, 2021
Threads
6,205
Likes
1,915
Credits
32,754©
Cash
0$
Lexeo Therapeutics, Inc. (LXEO), a company specializing in genetic medicine, has announced the immediate appointment of Kyle Rasbach as its Chief Financial Officer. Prior to joining Lexeo, Rasbach held the position of Chief Business Officer at Zentalis Pharmaceuticals. As of Wednesday, Lexeo's shares fell by 8.62%, closing at $6.36 on the Nasdaq.

The material has been provided by InstaForex Company - www.instaforex.com
 
Status
Not open for further replies.
Tips
Top Bottom